Geffen Residence & Renewal Ltd (TLV:GEFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 74.90
+1.60 (2.18%)
Oct 5, 2025, 3:49 PM IDT
TLV:GEFR Market Cap
TLV:GEFR has a market cap or net worth of 163.37 million as of October 7, 2025. Its market cap has increased by 26.61% in one year.
Market Cap
163.37M
Enterprise Value
215.92M
Revenue
-501.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
74.90
Market Cap Chart
Since December 20, 2018, TLV:GEFR's market cap has increased from 29.33M to 163.37M, an increase of 457.08%. That is a compound annual growth rate of 28.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2025 | 163.37M | 9.82% |
| Dec 31, 2024 | 148.76M | 47.72% |
| Dec 31, 2023 | 100.70M | 61.09% |
| Dec 29, 2022 | 62.51M | 89.46% |
| Dec 30, 2021 | 33.00M | -64.80% |
| Dec 31, 2020 | 93.74M | 338.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 75.93B |
| Danel (Adir Yeoshua) | 3.10B |
| Kamada | 1.31B |
| Bait Bakfar | 1.01B |
| BrainsWay | 977.55M |
| SofWave Medical | 960.10M |
| Ilex Medical | 714.47M |
| Novolog (Pharm-Up 1966) | 649.83M |